Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TIGIT Antikörper (AA 22-141)

TIGIT Reaktivität: Human ELISA, FACS, Coat, IHC (f) Wirt: Maus Monoclonal TIGIT-3017 unconjugated
Produktnummer ABIN6938572
  • Target Alle TIGIT Antikörper anzeigen
    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
    Bindungsspezifität
    • 10
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-141
    Reaktivität
    • 23
    • 14
    • 1
    Human
    Wirt
    • 19
    • 16
    • 1
    • 1
    Maus
    Klonalität
    • 20
    • 15
    • 2
    Monoklonal
    Konjugat
    • 23
    • 4
    • 4
    • 3
    • 2
    • 1
    Dieser TIGIT Antikörper ist unkonjugiert
    Applikation
    • 15
    • 14
    • 14
    • 11
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Flow Cytometry (FACS), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation). It has been demonstrated to be upregulated on T cells in many cancers and is an immuno-oncology target for therapy.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant fragment (around aa 22-141) of human TIGIT protein (exact sequence is proprietary)
    Klon
    TIGIT-3017
    Isotyp
    IgG2c kappa
    Top Product
    Discover our top product TIGIT Primärantikörper
  • Applikationshinweise

    Known_Application: ELISA (For coating, order antibody without BSA), Flow Cytometry (1-2 μg/million cells),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: MOLT-4, Prostate or Colon Carcinoma.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
    Andere Bezeichnung
    TIGIT (TIGIT Produkte)
    Synonyme
    VSIG9 antikoerper, VSTM3 antikoerper, WUCAM antikoerper, ENSMUSG00000071552 antikoerper, Vstm3 antikoerper, RGD1563191 antikoerper, T-cell immunoreceptor with Ig and ITIM domains antikoerper, T cell immunoreceptor with Ig and ITIM domains antikoerper, TIGIT antikoerper, Tigit antikoerper
    Hintergrund
    T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain containing 9 (VSIG9), V-set and transmembrane domain containing 3 (VSTM3), Washington University cell adhesion molecule (WUCAM),TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer)
    Cellular localisation: Cell Surface
    Molekulargewicht
    26kDa
    Gen-ID
    201633, 421750
    Pathways
    Cancer Immune Checkpoints
Sie sind hier:
Kundenservice